HM Capital
VC Fund
Dallas, United States
HM Capital is a VC fund in Dallas focused on Internet and Software. HM Capital Partners is a sector-focused private equity firm that primarily makes control investments in the energy, food, and media industries, where the Firm has extensive experience, expertise, relationships, and access to differentiated deal flow. Since its inception, the firm has completed more than 150 transactions in these sectors for atotal transaction value in excess of $26 billion.
- Total investments:
- 30
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries HM Capital invests in
Stages HM Capital invests in
Countries HM Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Series A
- $7.6M–$140M
- Series B
- $8.2M–$80M
Investment Focus
Industry
- Internet 15 (50%)
- Software 6 (20%)
- Biotechnology 5 (17%)
- Pharmaceutical 4 (13%)
- Marketing 3 (10%)
Stage
- Funding Round 9 (30%)
- Series A 7 (23%)
- Series B 6 (20%)
- Series C 4 (13%)
- Series D 1 (3%)
Country
- United States 19 (63%)
- China 2 (7%)
- Spain 2 (7%)
- Argentina 2 (7%)
- Brazil 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Eric C. Neuman
Partner & Managing Director
|
Partner & Managing Director | Total investments: 0 | Find email | |
|
John Muse
Chairman
|
Chairman | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OncoC4
|
OncoC4 is a clinical-stage biotechnology company that is actively engaged in the discovery and development of novel biologics for the potential treatment of cancer and neurodegenerative disease. | $50M / Series B / Oct 02, 2025 | |
Porton Advanced Solutions
|
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services. | $80M / Series B / Aug 21, 2022 | |
GenFleet Therapeutics
|
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize thebody's own immune system. | $78.7M / Series C / Dec 31, 2021 | |
Osteal Therapeutics
|
Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection. | $30M / Series B / Dec 29, 2021 | |
Sagimet Biosciences
|
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a pipeline of proprietary FASNinhibitors. | $80M / Venture - Series Unknown / Feb 11, 2021 | |
Canpages
|
Canpages is Canada's fastest growing local search company. Providing a multimedia platform that focuses on relevant, local results, Canpages offers many choices with online, print and mobile options.Canpages.ca is Canada’s national online directory for local business and residential searches. In excess of 3.5 million unique visitors come tovisit the site every month with their local search requests.Rich and relevant local content sets Canpages.ca apart from other directories, including photos, videos, and other immersive media. Canpages’ robust online directory combines comprehensive data and unique user experience with maps and satellite images provided by Bing.With 69 print publications and thousands of customers, Canpages reaches millions of households and businesses across Canada. Canpages publishes local telephone directories across Ontario, British Columbia, and Alberta.Canpages offers advanced mobile search technologies and multiple search possibilities with free text messages to mobile phones, mobile maps, direct SMS search, and advanced WAP and iPhone mobile browsing experiences.Canpages Inc. is owned by Yellow Media Inc., a subsidiary of Yellow Pages Income Fund. Headquartered in Vancouver, Canpages employs 700 people and has offices in Alberta, British Columbia, and Ontario. | $110M / Private Equity / Dec 01, 2005 | |
Vectrix
|
Vectrix is a full-service provider (FSP) of e-business solutions. They combine strategy, creative, marketing and technology to provide a unique client-centric approach that ensures a successful solution. Vectrix surpasses the competition by delivering core e-business competencies in a highly focused, tightly integrated manner. Producing awinning e-business solution takes a full range of services. With expertise in every area of an e-business solution, Vectrix produces all of the results that you need from a single partner-without the hassles of the piecemeal approach. That's why at Vectrix they say, "One partner. One invoice. No finger pointing." Whether your goal is to inform, educate, entertain, or create new revenue channels, make Vectrix your FSP. Vectrix is a privately held company based in Dallas, Texas. Founded in April 1996, they proudly boast 300+ exceptional employees | $25M / Jul 13, 2000 | |
Dgolpe
|
Dgolpe First select your language and then click the button below to enter the first global guide Internet music. | $8M / Jul 07, 2000 | |
Despegar
|
Despegar operates as an online business-to-consumer travel agency that focuses on the Portuguese and Spanish speaking markets. It enables people to research travel plans, check flight availability, book airline, and hotel and car rental reservations online, as well as offer travel-related services, including access to airlines, car rentalcompanies, and hotels and vacation packages. The company serves the leisure and corporate travelers. It operates in Argentina, Brazil, Chile, Colombia, Mexico, Uruguay, Venezuela, Spain, and the United States. The company was founded in 1999 and is based in Miami, Florida. | $10.5M / Series A / May 25, 2000 | |
Altitude Software
|
Altitude Software is a global provider of omnichannel software solutions for contact centers and departments interacting with customers | $27.5M / Series C / May 12, 2000 | |
| See all 30 investments → | |||
Co-Investors
Flatiron Partners
3 deals together
Huimei Capital
3 deals together
Chase Capital Partners
2 deals together
Huagai Capital
2 deals together
Steel Connect
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does HM Capital invest in?
HM Capital invests primarily in Internet, Software and Biotechnology startups, most often at Funding Round and Series A stage. Most of the 30 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is HM Capital's check size?
HM Capital typically joins rounds of $7.6M–$140M at Series A and $8.2M–$80M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds HM Capital participates in.
How do I contact HM Capital?
Public channels for HM Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at HM Capital?
The team at HM Capital includes Eric C. Neuman (Partner & Managing Director) and John Muse (Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
